PolyNovo Limited (FRA:MFJ)

Market Cap	381.44M -51.9%
Revenue (ttm)	79.25M +20.7%
Net Income	5.61M +67.3%
EPS	0.01 +67.6%
Shares Out	n/a
PE Ratio	67.97
Forward PE	39.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	241
Open	0.5300
Previous Close	0.5600
Day's Range	0.5300 - 0.5300
52-Week Range	0.4800 - 1.1400
Beta	n/a
RSI	38.69
Earnings Date	Feb 20, 2026

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 301
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MFJ

Financial Performance

In fiscal year 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.

Financial numbers in AUD